Indications
Treatment of fibrodysplasia ossificans progressiva.
Composition
- Active substance
- palovarotene
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Sohonos
- Active substance
- palovarotene
- ATC code
- M09AX11
- Therapeutic area
- Myositis Ossificans
- Marketing authorisation holder
- Ipsen Pharma
- Status
- Refused
- Refused
- 17 Jul 2023
- EMA product number
- EMEA/H/C/004867